GlassScriptPhysician profile
Matthew D Bryant
NPI 1154890838
$7,754.88
in general payments reported to CMS, 2019-2025
47 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,629 · 2022: $1,999 · 2023: $1,616 · 2024: $1,050 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,126.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,036.58 | 2021-2025 | |
| Novo Nordisk INC | $864.24 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $747.15 | 2022-2025 | |
| Lilly USA, LLC | $687.28 | 2021-2024 | Mounjaro, Emgality, Jardiance |
| Astrazeneca Pharmaceuticals LP | $508.92 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Otsuka America Pharmaceutical, INC. | $324.64 | 2021-2025 | Rexulti, Nuedexta |
| Glaxosmithkline, LLC. | $280.79 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Biohaven Pharmaceuticals, INC. | $256.91 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $249.92 | 2022 | |
| Sanofi-Aventis U.S. LLC | $232.27 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $222.84 | 2021-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.92 | 2021-2023 | Jardiance |
| Preventric Diagnostics, INC. | $200.15 | 2021 | |
| Daiichi Sankyo INC. | $193.44 | 2021-2024 | Injectafer |
| Eisai INC. | $132.60 | 2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.